SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-114878
Filing Date
2017-04-07
Accepted
2017-04-07 07:46:56
Documents
7
Effectiveness Date
2017-04-07

Document Format Files

Seq Description Document Type Size
1 DEFA14A d334445ddefa14a.htm DEFA14A 36243
2 GRAPHIC g334445g05e15.jpg GRAPHIC 23408
3 GRAPHIC g334445g16q56.jpg GRAPHIC 13701
4 GRAPHIC g334445g50i50.jpg GRAPHIC 16914
5 GRAPHIC g334445g62d05.jpg GRAPHIC 24728
6 GRAPHIC g334445g76c99.jpg GRAPHIC 32714
7 GRAPHIC g334445g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-17-114878.txt   209380
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36296 | Film No.: 17747625
SIC: 2834 Pharmaceutical Preparations